Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider
View original at globenewswire.comUterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider Austin, United States, Feb…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
The U.S. Uterine Fibroid Market size was valued at USD 1.78 Billion in 2025E and is projected to reach USD 3.11 Billion by 2033, growing at a CAGR of 7.25% during 2026-2033
80% confidenceThe Uterine Fibroid Market size was valued at USD 5.26 Billion in 2025 and is projected to reach USD 9.43 Billion by 2033 and grow at a CAGR of 7.63% over the forecast period 2026-2033
80% confidenceHospitals & Clinics dominated with 47.49% market share in 2025
80% confidenceSurgical Procedures dominated with 38.45% in 2025 due to their proven effectiveness, widespread availability, and established clinical use
80% confidenceNorth America is predicted to hold a 45.32% market share in 2025 for uterine fibroids
80% confidenceUterine fibroids occur in approximately 70 to 80% of women by the age of 50
80% confidenceMinimally invasive techniques, including laparoscopic myomectomy, uterine artery embolization, and MRI-guided focused ultrasound, have seen adoption rates rise by more than 60% in the past five years
80% confidenceNorth America is predicted to hold a 45.32% market share in 2025 for uterine fibroids
80% confidenceMRI-Guided Focused Ultrasound (MRgFUS) is expected to grow at the fastest CAGR of 8.83% from 2026 to 2033
80% confidenceSurgical Procedures dominated with 38.45% in 2025 due to their proven effectiveness, widespread availability, and established clinical use
80% confidenceHospitals & Clinics dominated with 47.49% in 2025 due to their advanced infrastructure and specialized care
80% confidenceAsia Pacific is expected to grow at the fastest CAGR from 2026-2033 in the Uterine Fibroid Market
80% confidenceMinimally Invasive Procedures is expected to grow at the fastest CAGR of 8.63% from 2026 to 2033
80% confidenceAfrican American women have a high risk of uterine fibroids, occurring at a younger age with severe symptoms compared to other ethnicities
80% confidenceLaparoscopic Surgery dominated with 36.58% market share in 2025
80% confidenceUterine fibroids are common among women between the ages of 30 to 40 years
80% confidenceUterine fibroids are common among women between the ages of 30 to 40 years, with varying rates among different ethnic groups
80% confidenceHealthcare expenditures in developing regions have grown by an approximate 45% over the last decade
80% confidenceAsia Pacific is expected to grow at the fastest CAGR from 2026-2033 in the Uterine Fibroid Market
80% confidenceSurgical Procedures dominated with 38.45% market share in 2025
80% confidenceMRI-Guided Focused Ultrasound expected to grow at the fastest CAGR of 8.83% from 2026 to 2033
80% confidenceSubmucosal Fibroids dominated with 36.24% in 2025 due to their high prevalence and significant symptom severity
80% confidenceAmbulatory Surgical Centers is expected to grow at the fastest CAGR of 8.43% from 2026 to 2033
80% confidenceUterine fibroids occur in approximately 70 to 80% of women by the age of 50
80% confidenceMRI-Guided Focused Ultrasound (MRgFUS) is expected to grow at the fastest CAGR of 8.83% from 2026 to 2033
80% confidenceThe U.S. Uterine Fibroid Market size was valued at USD 1.78 Billion in 2025 and is projected to reach USD 3.11 Billion by 2033, growing at a CAGR of 7.25%
80% confidenceLaparoscopic Surgery dominated with 36.58% market share in 2025
80% confidenceSubmucosal Fibroids dominated with 36.24% market share in 2025
80% confidenceLaparoscopic Surgery dominated with 36.58% market share in 2025
80% confidenceMRI-Guided Focused Ultrasound (MRgFUS) is expected to grow at the fastest CAGR of 8.83% from 2026 to 2033
80% confidence